NeuroPace, Inc.NPCENASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-13.80%
↑ 67% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
-42.46%
Historical baseline
PeriodValueYoY Change
TTM-13.80%+33.5%
2024-20.74%+40.6%
2023-34.90%+56.6%
2022-80.33%-27.9%
2021-62.80%-107.0%
2020-30.34%+44.1%
2019-54.28%-